BioMarin Pharmaceutical Inc. buy Piper Sandler
Start price
23.02.24
/
50%
€84.34
Target price
23.02.25
€98.83
Performance (%)
-22.62%
End price
24.02.25
€65.26
Summary
This prediction ended on 24.02.25 with a price of €65.26. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -22.62%. Piper_Sandler has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.079% | -0.079% | -23.691% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
Comments by Piper_Sandler for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Piper Sandler from $115.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.34
20.02.25
20.02.25
€120.57
20.02.26
20.02.26
-25.81%
09.01.26
09.01.26
Stopped prediction by Piper_Sandler for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.46
05.09.24
05.09.24
€109.96
05.09.25
05.09.25
-34.85%
06.09.25
06.09.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.88
27.08.24
27.08.24
€95.81
27.08.25
27.08.25
-38.16%
28.08.25
28.08.25